Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Comparing two therapies for schizophrenia-spectrum disorders and psychosis

Compares talking therapy and brain-training therapy in adults with schizophrenia-spectrum disorders.

Plain-language title generated from the registry record
Registry title: Outcomes From Remediation and Behavioural Intervention Techniques

Key facts

Where
Scarborough Village and Whitby, CanadaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT05731414, who can take part

Where in Canada

  • University of Toronto ScarboroughScarborough Village, CanadaTaking people
  • Ontario Shores Centre for Mental Health Sciences (Ontario Shores)Whitby, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Toronto
Trial code
NCT05731414
Record updated
19 August 2025
Original description
It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.Read full original descriptionShow less

Cognitive Behavioural Therapy Compared to Cognitive Remediation for Schizophrenia-Spectrum Disorders

It is currently unknown what factors predict response to Cognitive Behavioural Therapy for Psychosis (CBTp) or Cognitive Remediation Therapy (CR) among individuals with schizophrenia-spectrum disorders, thus the current trial will examine predictors of response to determine who requires the combined intervention and who might respond sufficiently to either monotherapy.

Inclusion: Aged 18-65 years; Diagnosed with schizophrenia-spectrum disorders; Can read, write, and speak English.

Exclusion: Neurodevelopmental disability or neurocognitive disorder; CBT or CR in the past 6 months.

ClinicalTrials.gov NCT05731414